Alife Health Partners with Boston IVF on AI Technology for IVF Treatment Optimization

Must Read

The collaboration between Alife Health and Boston IVF aims to optimize patients’ IVF cycles through data-driven decisions

SAN FRANCISCO and BOSTON, March 12, 2024 /PRNewswire/ — Alife Health (“Alife”), a leading fertility technology company specializing in the development of AI tools for in vitro fertilization (IVF), has announced a groundbreaking partnership with Boston IVF, a leading fertility clinic with more than 25 locations across the U.S., to pilot the country’s first AI tool for IVF medication optimization. Boston IVF will implement Alife’s Stim Assist software, which is designed to help IVF clinicians retrieve the optimal number of eggs for each patient and reduce overall medication costs.